Reports - Immunoassay Market
ChemicalsImmunoassay Market
Immunoassay Market Trends, Growth & Innovations (2025–2035) by Product Type (Reagents & Kits, Analyzers/Instruments, Software & Services) by Specimen (Blood, Serum/Plasma, Saliva, Urine, Tissue Samples, Others) by Technology (Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA), Chemiluminescent Immunoassay (CLIA), Fluorescent Immunoassay (FIA), Rapid Tests (Lateral Flow Assays, Immunochromatographic Assays), Western Blot, Nephelometric and Turbidimetric Immunoassays, Electrochemiluminescence Immunoassay (ECLIA), Other Emerging Technologies) by Application (Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Others) by End Use (Hospitals & Clinics, Diagnostic Laboratories, Research & Academic Institutes, Pharmaceutical & Biotechnology Companies, Blood Banks & Organ Transplant Centers, Home Care Settings, Veterinary Clinics & Diagnostic Labs) by Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Immunoassay Market - Segment Analysis
1. Overview
2. Global Immunoassay Market, 2021 - 2035 (USD Million)
3. Global Immunoassay Market - by Product Type
3.1. By Reagents & Kits
3.2. By Analyzers/Instruments
3.3. By Software & Services
4. Global Immunoassay Market - by Specimen
4.1. By Blood
4.2. By Serum/Plasma
4.3. By Saliva
4.4. By Urine
4.5. By Tissue Samples
4.6. By Others
5. Global Immunoassay Market - by Technology
5.1. By Enzyme-Linked Immunosorbent Assay (ELISA)
5.2. By Radioimmunoassay (RIA)
5.3. By Chemiluminescent Immunoassay (CLIA)
5.4. By Fluorescent Immunoassay (FIA)
5.5. By Rapid Tests (Lateral Flow Assays, Immunochromatographic Assays)
5.6. By Western Blot
5.7. By Nephelometric and Turbidimetric Immunoassays
5.8. By Electrochemiluminescence Immunoassay (ECLIA)
5.9. By Other Emerging Technologies
6. Global Immunoassay Market - by Application
6.1. By Therapeutic Drug Monitoring
6.2. By Oncology
6.3. By Cardiology
6.4. By Endocrinology
6.5. By Infectious Disease Testing
6.6. By Autoimmune Diseases
6.7. By Others
7. Global Immunoassay Market - by End Use
7.1. By Hospitals & Clinics
7.2. By Diagnostic Laboratories
7.3. By Research & Academic Institutes
7.4. By Pharmaceutical & Biotechnology Companies
7.5. By Blood Banks & Organ Transplant Centers
7.6. By Home Care Settings
7.7. By Veterinary Clinics & Diagnostic Labs
8. Global Immunoassay Market - by region
8.1. North America
8.2. Europe
8.3. Asia Pacific
8.4. Latin America
8.5. Middle East & Africa
9. Market comparative analysis
Chapter 4 North America Immunoassay Market - Segment Analysis
1. Overview
2. North America Immunoassay Market, 2021 - 2035 (USD Million)
3. North America Immunoassay Market - by Product Type
3.1. By Reagents & Kits
3.2. By Analyzers/Instruments
3.3. By Software & Services
4. North America Immunoassay Market - by Specimen
4.1. By Blood
4.2. By Serum/Plasma
4.3. By Saliva
4.4. By Urine
4.5. By Tissue Samples
4.6. By Others
5. North America Immunoassay Market - by Technology
5.1. By Enzyme-Linked Immunosorbent Assay (ELISA)
5.2. By Radioimmunoassay (RIA)
5.3. By Chemiluminescent Immunoassay (CLIA)
5.4. By Fluorescent Immunoassay (FIA)
5.5. By Rapid Tests (Lateral Flow Assays, Immunochromatographic Assays)
5.6. By Western Blot
5.7. By Nephelometric and Turbidimetric Immunoassays
5.8. By Electrochemiluminescence Immunoassay (ECLIA)
5.9. By Other Emerging Technologies
6. North America Immunoassay Market - by Application
6.1. By Therapeutic Drug Monitoring
6.2. By Oncology
6.3. By Cardiology
6.4. By Endocrinology
6.5. By Infectious Disease Testing
6.6. By Autoimmune Diseases
6.7. By Others
7. North America Immunoassay Market - by End Use
7.1. By Hospitals & Clinics
7.2. By Diagnostic Laboratories
7.3. By Research & Academic Institutes
7.4. By Pharmaceutical & Biotechnology Companies
7.5. By Blood Banks & Organ Transplant Centers
7.6. By Home Care Settings
7.7. By Veterinary Clinics & Diagnostic Labs
Chapter 5 Europe Immunoassay Market - Segment Analysis
1. Overview
2. Europe Immunoassay Market, 2021 - 2035 (USD Million)
3. Europe Immunoassay Market - by Product Type
3.1. By Reagents & Kits
3.2. By Analyzers/Instruments
3.3. By Software & Services
4. Europe Immunoassay Market - by Specimen
4.1. By Blood
4.2. By Serum/Plasma
4.3. By Saliva
4.4. By Urine
4.5. By Tissue Samples
4.6. By Others
5. Europe Immunoassay Market - by Technology
5.1. By Enzyme-Linked Immunosorbent Assay (ELISA)
5.2. By Radioimmunoassay (RIA)
5.3. By Chemiluminescent Immunoassay (CLIA)
5.4. By Fluorescent Immunoassay (FIA)
5.5. By Rapid Tests (Lateral Flow Assays, Immunochromatographic Assays)
5.6. By Western Blot
5.7. By Nephelometric and Turbidimetric Immunoassays
5.8. By Electrochemiluminescence Immunoassay (ECLIA)
5.9. By Other Emerging Technologies
6. Europe Immunoassay Market - by Application
6.1. By Therapeutic Drug Monitoring
6.2. By Oncology
6.3. By Cardiology
6.4. By Endocrinology
6.5. By Infectious Disease Testing
6.6. By Autoimmune Diseases
6.7. By Others
7. Europe Immunoassay Market - by End Use
7.1. By Hospitals & Clinics
7.2. By Diagnostic Laboratories
7.3. By Research & Academic Institutes
7.4. By Pharmaceutical & Biotechnology Companies
7.5. By Blood Banks & Organ Transplant Centers
7.6. By Home Care Settings
7.7. By Veterinary Clinics & Diagnostic Labs
Chapter 6 Asia Pacific Immunoassay Market - Segment Analysis
1. Overview
2. Asia Pacific Immunoassay Market, 2021 - 2035 (USD Million)
3. Asia Pacific Immunoassay Market - by Product Type
3.1. By Reagents & Kits
3.2. By Analyzers/Instruments
3.3. By Software & Services
4. Asia Pacific Immunoassay Market - by Specimen
4.1. By Blood
4.2. By Serum/Plasma
4.3. By Saliva
4.4. By Urine
4.5. By Tissue Samples
4.6. By Others
5. Asia Pacific Immunoassay Market - by Technology
5.1. By Enzyme-Linked Immunosorbent Assay (ELISA)
5.2. By Radioimmunoassay (RIA)
5.3. By Chemiluminescent Immunoassay (CLIA)
5.4. By Fluorescent Immunoassay (FIA)
5.5. By Rapid Tests (Lateral Flow Assays, Immunochromatographic Assays)
5.6. By Western Blot
5.7. By Nephelometric and Turbidimetric Immunoassays
5.8. By Electrochemiluminescence Immunoassay (ECLIA)
5.9. By Other Emerging Technologies
6. Asia Pacific Immunoassay Market - by Application
6.1. By Therapeutic Drug Monitoring
6.2. By Oncology
6.3. By Cardiology
6.4. By Endocrinology
6.5. By Infectious Disease Testing
6.6. By Autoimmune Diseases
6.7. By Others
7. Asia Pacific Immunoassay Market - by End Use
7.1. By Hospitals & Clinics
7.2. By Diagnostic Laboratories
7.3. By Research & Academic Institutes
7.4. By Pharmaceutical & Biotechnology Companies
7.5. By Blood Banks & Organ Transplant Centers
7.6. By Home Care Settings
7.7. By Veterinary Clinics & Diagnostic Labs
Chapter 7 Latin America Immunoassay Market - Segment Analysis
1. Overview
2. Latin America Immunoassay Market, 2021 - 2035 (USD Million)
3. Latin America Immunoassay Market - by Product Type
3.1. By Reagents & Kits
3.2. By Analyzers/Instruments
3.3. By Software & Services
4. Latin America Immunoassay Market - by Specimen
4.1. By Blood
4.2. By Serum/Plasma
4.3. By Saliva
4.4. By Urine
4.5. By Tissue Samples
4.6. By Others
5. Latin America Immunoassay Market - by Technology
5.1. By Enzyme-Linked Immunosorbent Assay (ELISA)
5.2. By Radioimmunoassay (RIA)
5.3. By Chemiluminescent Immunoassay (CLIA)
5.4. By Fluorescent Immunoassay (FIA)
5.5. By Rapid Tests (Lateral Flow Assays, Immunochromatographic Assays)
5.6. By Western Blot
5.7. By Nephelometric and Turbidimetric Immunoassays
5.8. By Electrochemiluminescence Immunoassay (ECLIA)
5.9. By Other Emerging Technologies
6. Latin America Immunoassay Market - by Application
6.1. By Therapeutic Drug Monitoring
6.2. By Oncology
6.3. By Cardiology
6.4. By Endocrinology
6.5. By Infectious Disease Testing
6.6. By Autoimmune Diseases
6.7. By Others
7. Latin America Immunoassay Market - by End Use
7.1. By Hospitals & Clinics
7.2. By Diagnostic Laboratories
7.3. By Research & Academic Institutes
7.4. By Pharmaceutical & Biotechnology Companies
7.5. By Blood Banks & Organ Transplant Centers
7.6. By Home Care Settings
7.7. By Veterinary Clinics & Diagnostic Labs
Chapter 8 Middle East & Africa Immunoassay Market - Segment Analysis
1. Overview
2. Middle East & Africa Immunoassay Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Immunoassay Market - by Product Type
3.1. By Reagents & Kits
3.2. By Analyzers/Instruments
3.3. By Software & Services
4. Middle East & Africa Immunoassay Market - by Specimen
4.1. By Blood
4.2. By Serum/Plasma
4.3. By Saliva
4.4. By Urine
4.5. By Tissue Samples
4.6. By Others
5. Middle East & Africa Immunoassay Market - by Technology
5.1. By Enzyme-Linked Immunosorbent Assay (ELISA)
5.2. By Radioimmunoassay (RIA)
5.3. By Chemiluminescent Immunoassay (CLIA)
5.4. By Fluorescent Immunoassay (FIA)
5.5. By Rapid Tests (Lateral Flow Assays, Immunochromatographic Assays)
5.6. By Western Blot
5.7. By Nephelometric and Turbidimetric Immunoassays
5.8. By Electrochemiluminescence Immunoassay (ECLIA)
5.9. By Other Emerging Technologies
6. Middle East & Africa Immunoassay Market - by Application
6.1. By Therapeutic Drug Monitoring
6.2. By Oncology
6.3. By Cardiology
6.4. By Endocrinology
6.5. By Infectious Disease Testing
6.6. By Autoimmune Diseases
6.7. By Others
7. Middle East & Africa Immunoassay Market - by End Use
7.1. By Hospitals & Clinics
7.2. By Diagnostic Laboratories
7.3. By Research & Academic Institutes
7.4. By Pharmaceutical & Biotechnology Companies
7.5. By Blood Banks & Organ Transplant Centers
7.6. By Home Care Settings
7.7. By Veterinary Clinics & Diagnostic Labs
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Danaher
2. Thermo Fisher Scientific
3. Abbott Laboratories
4. Roche
5. Siemens Healthineer
6. Quidel
7. DiaSorin
8. bioMérieux
9. Bio-Rad Laboratories
10. Ortho Clinical Diagnostics
11. PerkinElmer
12. Becton Dickinson & Company
13. Sysmex
14. Agilent Technologies
15. Mindray
16. QIAGEN
17. Merk KGaA
18. Bio-Techne
19. Cellabs
20. Abnova Corporation
21. J. Mitra & Co. Pvt. Ltd.
22. Tosoh Corporation
23. Cell Sciences
24. Enzo Biochem Inc.
25. Creative Diagnostics
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By